Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Grants

Publications

Muir, Andrew J., Dawn Provenzale, and Jane E. Onken. “Fistulous complications in Crohn's disease: Impact on health related quality of life (HRQL) and resource utilization.” Gastroenterology 118, no. 4 (April 2000): A585–A585. https://doi.org/10.1016/s0016-5085(00)84477-7.

Full Text

Palker, T. J., A. J. Muir, D. E. Spragion, H. F. Staats, A. Langlois, and D. C. Montefiori. “The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.” Virology 224, no. 2 (October 15, 1996): 415–26. https://doi.org/10.1006/viro.1996.0548.

PMID
8874502
Full Text

Palker, T. J., E. R. Riggs, D. E. Spragion, A. J. Muir, R. M. Scearce, R. R. Randall, M. W. McAdams, A. McKnight, P. R. Clapham, and R. A. Weiss. “Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.” J Virol 66, no. 10 (October 1992): 5879–89. https://doi.org/10.1128/JVI.66.10.5879-5889.1992.

PMID
1326649
Full Text

Pages